Application Notes & Case Studies

  1. Successful Tech Transfer Meets Commercial Needs 5/5/2026

    An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.

  2. Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms 4/27/2026

    Spray drying enables stable, scalable dry‑powder nasal biologics, improving shelf life, particle control, and targeted delivery for peptides, proteins, vaccines, and oligonucleotides.

  3. Stability With IDBS Polar 4/24/2026

    Manual tracking often leads to missed pulls and data gaps. Discover how a connected digital workflow governs stability execution, ensuring consistency and regulatory confidence at every timepoint.

  4. Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation System 4/21/2026

    Learn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.

  5. Robust, High-Throughput Automated Solution For Water Endotoxin Testing 4/21/2026

    High-throughput water endotoxin testing doesn’t have to sacrifice consistency. Gain insight into how an automated workflow delivers reliable results, low variability, and strong control recovery.

  6. Anticoagulant Selection Influences T Cell Purity And Yield In Whole Blood Isolation 4/21/2026

    Lithium heparin reduces T cell purity to below 50% and spikes CD15+ contamination in whole blood workflows. See which anticoagulants consistently deliver above 90% CD3+ purity.

  7. Maintain Control Of Pharmaceutical Water Systems 4/10/2026

    Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

  8. Evaluating Carryover When Using A TOC Analyzer 4/10/2026

    Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

  9. Scale-Up Of AAV Production In Fixed-Bed Bioreactors 3/31/2026

    Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.

  10. Demonstrating Bioprocess Scalability Through Platform Consistency 3/25/2026

    Explore how a unified bioreactor design enables consistent process performance from bench to production, minimizing scale-up risk while maintaining cell growth and yield.